# Prudential Financial Inc: financial statements, quarterly

PRU · NYSE · CIK 1137774 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pru.md) · [Financials](/companies/pru/financials.md) · [Filings](/companies/pru/filings.md) · [Insiders](/companies/pru/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pru/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $bn | [8.4](/filings/0001137774-24-000247.md) | [15.1](/filings/0001137774-24-000045.md) | [23.5](/filings/0001137774-25-000060.md) | [14.9](/filings/0001137774-25-000108.md) | [19.5](/filings/0001137774-25-000178.md) | [12.5 d](/filings/0001137774-26-000048.md) | [13.5](/filings/0001137774-26-000095.md) | [13.7](/filings/0001137774-26-000176.md) | [17.9](/filings/0001137774-25-000178.md) | [15.7 d](/filings/0001137774-26-000048.md) | [15.5](/filings/0001137774-26-000095.md) | [15.7](/filings/0001137774-26-000176.md) |
| Selling, general and administrative | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $bn | [0.4](/filings/0001137774-23-000117.md) | [0.4 d](/filings/0001137774-25-000044.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $bn | [(0.3)](/filings/0001137774-24-000247.md) | [0.4 d](/filings/0001137774-26-000048.md) | [0.3](/filings/0001137774-25-000060.md) | [0.3](/filings/0001137774-25-000108.md) | [0.1](/filings/0001137774-25-000178.md) | [(0.2) d](/filings/0001137774-26-000048.md) | [0.2](/filings/0001137774-26-000095.md) | [0.2](/filings/0001137774-26-000176.md) | [0.4](/filings/0001137774-25-000178.md) | [0.3 d](/filings/0001137774-26-000048.md) | [0.1](/filings/0001137774-26-000095.md) | [0.2](/filings/0001137774-26-000176.md) |
| Net income | $bn | [(0.8)](/filings/0001137774-24-000247.md) | [1.3](/filings/0001137774-24-000045.md) | [1.1](/filings/0001137774-25-000060.md) | [1.2](/filings/0001137774-25-000108.md) | [0.4](/filings/0001137774-25-000178.md) | [(0.1) d](/filings/0001137774-26-000048.md) | [0.7](/filings/0001137774-26-000095.md) | [0.5](/filings/0001137774-26-000176.md) | [1.4](/filings/0001137774-25-000178.md) | [0.9 d](/filings/0001137774-26-000048.md) | [0.6](/filings/0001137774-26-000095.md) | [1.0](/filings/0001137774-26-000176.md) |
| Diluted EPS | $ per share | [(2.23)](/filings/0001137774-24-000247.md) | [3.61](/filings/0001137774-24-000045.md) | [3.12](/filings/0001137774-25-000060.md) | [3.28](/filings/0001137774-25-000108.md) | [1.24](/filings/0001137774-25-000178.md) | not reported | [1.96](/filings/0001137774-26-000095.md) | [1.48](/filings/0001137774-26-000176.md) | [4.01](/filings/0001137774-25-000178.md) | not reported | [1.68](/filings/0001137774-26-000095.md) | [2.80](/filings/0001137774-26-000176.md) |
| Basic EPS | $ per share | [(2.23)](/filings/0001137774-24-000247.md) | [3.62](/filings/0001137774-24-000045.md) | [3.13](/filings/0001137774-25-000060.md) | [3.30](/filings/0001137774-25-000108.md) | [1.24](/filings/0001137774-25-000178.md) | not reported | [1.97](/filings/0001137774-26-000095.md) | [1.49](/filings/0001137774-26-000176.md) | [4.03](/filings/0001137774-25-000178.md) | not reported | [1.69](/filings/0001137774-26-000095.md) | [2.81](/filings/0001137774-26-000176.md) |

- Revenue: us-gaap:Revenues
- Selling, general and administrative: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [16.9](/filings/0001137774-24-000247.md) | [19.4](/filings/0001137774-26-000048.md) | [18.7](/filings/0001137774-25-000060.md) | [17.1](/filings/0001137774-25-000108.md) | [20.2](/filings/0001137774-25-000178.md) | [18.5](/filings/0001137774-26-000048.md) | [16.1](/filings/0001137774-26-000095.md) | [16.6](/filings/0001137774-26-000176.md) | [17.5](/filings/0001137774-25-000178.md) | [19.7](/filings/0001137774-26-000176.md) | [15.9](/filings/0001137774-26-000095.md) | [15.2](/filings/0001137774-26-000176.md) |
| Total assets | $bn | [681](/filings/0001137774-23-000117.md) | [721](/filings/0001137774-25-000044.md) | [726](/filings/0001137774-24-000068.md) | [715](/filings/0001137774-24-000151.md) | [760](/filings/0001137774-24-000247.md) | [736](/filings/0001137774-26-000048.md) | [739](/filings/0001137774-25-000060.md) | [759](/filings/0001137774-25-000108.md) | [776](/filings/0001137774-25-000178.md) | [774](/filings/0001137774-26-000176.md) | [765](/filings/0001137774-26-000095.md) | [784](/filings/0001137774-26-000176.md) |
| Total liabilities | $bn | [654](/filings/0001137774-23-000117.md) | [691](/filings/0001137774-25-000044.md) | [696](/filings/0001137774-24-000068.md) | [685](/filings/0001137774-24-000151.md) | [728](/filings/0001137774-24-000247.md) | [705](/filings/0001137774-26-000048.md) | [707](/filings/0001137774-25-000060.md) | [726](/filings/0001137774-25-000108.md) | [741](/filings/0001137774-25-000178.md) | [738](/filings/0001137774-26-000176.md) | [730](/filings/0001137774-26-000095.md) | [749](/filings/0001137774-26-000176.md) |
| Long-term debt | $bn | [18.9](/filings/0001137774-23-000117.md) | [18.9](/filings/0001137774-25-000044.md) | [19.4](/filings/0001137774-24-000068.md) | [19.4](/filings/0001137774-24-000151.md) | [19.1](/filings/0001137774-24-000247.md) | [19.2](/filings/0001137774-26-000048.md) | [19.5](/filings/0001137774-25-000060.md) | [18.7](/filings/0001137774-25-000108.md) | [18.8](/filings/0001137774-25-000178.md) | [18.9](/filings/0001137774-26-000176.md) | [18.9](/filings/0001137774-26-000095.md) | [19.7](/filings/0001137774-26-000176.md) |
| Current portion of debt | $bn | [0.6](/filings/0001137774-23-000117.md) | [0.6](/filings/0001137774-25-000044.md) | [0.6](/filings/0001137774-24-000068.md) | [0.6](/filings/0001137774-24-000151.md) | [1.0](/filings/0001137774-24-000247.md) | [1.0](/filings/0001137774-26-000048.md) | [1.4](/filings/0001137774-25-000060.md) | [1.4](/filings/0001137774-25-000108.md) | [1.4](/filings/0001137774-25-000178.md) | [1.4](/filings/0001137774-26-000176.md) | [0.9](/filings/0001137774-26-000095.md) | [1.0](/filings/0001137774-26-000176.md) |
| Short-term borrowings | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [25.8](/filings/0001137774-23-000117.md) | [27.8](/filings/0001137774-25-000044.md) | [27.2](/filings/0001137774-24-000068.md) | [28.0](/filings/0001137774-24-000151.md) | [30.4](/filings/0001137774-24-000247.md) | [27.9](/filings/0001137774-26-000048.md) | [29.9](/filings/0001137774-25-000060.md) | [30.6](/filings/0001137774-25-000108.md) | [32.1](/filings/0001137774-25-000178.md) | [32.4](/filings/0001137774-26-000176.md) | [32.0](/filings/0001137774-26-000095.md) | [31.6](/filings/0001137774-26-000176.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:DebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2,840 d](/filings/0001137774-24-000247.md) | [1,103 d](/filings/0001137774-26-000048.md) | [5,221](/filings/0001137774-25-000060.md) | [(146) d](/filings/0001137774-25-000108.md) | [1,105 d](/filings/0001137774-25-000178.md) | [2,322 d](/filings/0001137774-26-000048.md) | [(2,506)](/filings/0001137774-26-000095.md) | [1,162 d](/filings/0001137774-26-000176.md) | [4,296 d](/filings/0001137774-25-000178.md) | [3,319 d](/filings/0001137774-26-000048.md) | [1,008](/filings/0001137774-26-000095.md) | [2,346 d](/filings/0001137774-26-000176.md) |
| Dividends paid | $m | [458 d](/filings/0001137774-24-000247.md) | [455 d](/filings/0001137774-26-000048.md) | [483](/filings/0001137774-25-000060.md) | [472 d](/filings/0001137774-25-000108.md) | [469 d](/filings/0001137774-25-000178.md) | [467 d](/filings/0001137774-26-000048.md) | [491](/filings/0001137774-26-000095.md) | [481 d](/filings/0001137774-26-000176.md) | [479 d](/filings/0001137774-25-000178.md) | [475 d](/filings/0001137774-26-000048.md) | [502](/filings/0001137774-26-000095.md) | [490 d](/filings/0001137774-26-000176.md) |
| Share repurchases | $m | [250 d](/filings/0001137774-24-000247.md) | [258 d](/filings/0001137774-26-000048.md) | [242](/filings/0001137774-25-000060.md) | [251 d](/filings/0001137774-25-000108.md) | [253 d](/filings/0001137774-25-000178.md) | [254 d](/filings/0001137774-26-000048.md) | [246](/filings/0001137774-26-000095.md) | [250 d](/filings/0001137774-26-000176.md) | [250 d](/filings/0001137774-25-000178.md) | [254 d](/filings/0001137774-26-000048.md) | [246](/filings/0001137774-26-000095.md) | [250 d](/filings/0001137774-26-000176.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [371](/filings/0001137774-23-000117.md) | [368](/filings/0001137774-24-000068.md) | [366](/filings/0001137774-24-000151.md) | [363](/filings/0001137774-24-000247.md) | [361](/filings/0001137774-25-000060.md) | [361](/filings/0001137774-25-000108.md) | [359](/filings/0001137774-25-000178.md) | [356](/filings/0001137774-26-000095.md) | [355](/filings/0001137774-26-000176.md) | [353](/filings/0001137774-25-000178.md) | [349](/filings/0001137774-26-000095.md) | [348](/filings/0001137774-26-000176.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 345,000,000 at 2026-07-31, from the cover of the [10-Q filed 2026-08-05](/filings/0001137774-26-000176.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.